Month: January 2025

PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions

BOSTON, MA / ACCESSWIRE / January 14, 2025 / PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company dedicated to advancing...

Integrative Providers Association (IPA), Coalition for Patient Rights (CPR) and Compassion Center Announce Unwavering Support for Robert F. Kennedy, Jr. as Secretary of Health and Human Services

error: Content is protected !!